The safety and efficacy of microwave ablation and radiofrequency ablation for colorectal cancer liver metastasis : A randomized controlled clinical trial - The safety and efficacy of microwave ablation and radiofrequency ablation for colorectal cancer liver metastasis : A randomized controlled clinical trial

Juntendo University0 个研究点目标入组 104 人开始时间: 2019年3月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.Patient with platelet of 50,000/mm3 or less. Patient with PT of 50% or less. 2. Patient with refractory ascites and at high risk of peritoneal bleeding 3. Patient with enterobiliary reflux 4. Contrast-enhanced CT cannot be performed because of renal dysfunction (creatinine of 2 mg/dL or more) or allergic adverse reactions to iodine contrast agents 5. ASA's (American Society of Anesthesiologists) physical score 3 or above 6. Patient who cannot accept necessary treatments, such as blood transfusion, because of religious reasons and others 7. Patient who cannot follow medical instructions because of dementia and others 8. Patient with tumors not visualized by ultrasonography or not accessible 9. Patient with adhesion between tumors and the gastrointestinal tract which may cause GI tract penetration or perforation 10.Patient with tumors adjacent to the major Glisson's capsule which may cause serious biliary injury or hepatic infarction 11.Patient not considered eligible to participate in this study by the attending doctor due to various reasons

发起方